{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Dallas",
      "address_1": "4001 McEwen Rd Suite 110",
      "reason_for_recall": "Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.",
      "address_2": "",
      "product_quantity": "122 vials",
      "code_info": "Lot #:N10172012@11, Exp 10/17/2013",
      "center_classification_date": "20140130",
      "distribution_pattern": "Nationwide",
      "state": "TX",
      "product_description": "Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244",
      "report_date": "20140205",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "NuVision Pharmacy, Inc.",
      "recall_number": "D-1052-2014",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "64922",
      "termination_date": "20170208",
      "more_code_info": "",
      "recall_initiation_date": "20130415",
      "postal_code": "75244-5020",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}